Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vacteta versus Tetavax booster vaccination in healthy adults
2016-004934-11Phase 4Completed
- Sponsor
- BioDrug
- Start
- Jan 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Tetanus Vaccine (Adsorbed) in Tetanus (2 arms), sponsored by BioDrug. Primary endpoints: Seroconversion rate for tetanus-specific antibodies and Tetanus-specific antibody concentration. Started Jan 2017; status: completed.
02
Drugs
Tetanus Vaccine (Adsorbed)
03
Conditions
Tetanus
Beyond the preview
Go deeper on 2016-004934-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004934-11.